Current Challenges in Managing Hemophilia

Slides:

Advertisements

Similar presentations

Primary Care Challenges in Depression - To Treat or Refer?

Advertisements

The Current Status of Neoadjuvant Therapy in HER2-Positive Breast Cancer.

Why Gene Therapy for Hemophilia?

RESISTANT HYPERTENSION OR POOR PATIENT ADHERENCE? TIPS TO GAIN CONTROL

MR Imaging in Children.

Acute Heart Failure.

Prophylaxis Considerations for Teenagers and Young Adults With Severe Hemophilia.

Thrombosis, Cancer, and NOACs

The Possibilities of PrEP: Introduction

Pediatric Antiepileptic Treatment Strategies

New Challenges Facing Multiple Sclerosis Nurses

Biological Therapy in Psoriasis: Recognizing the Value

Extended Half-life Factor Products in the Management of Hemophilia

Managing Hereditary Angioedema

Individualizing Prophylaxis in Hemophilia

Hot Topics in Hemophilia Nursing

Optimizing Outcomes in the Management of GIST

Issues in the Management of Hemophilia: A Best Practice Series

Program Goal. Program Goal Current Stroke Guidelines: AHA/ASA.

Surveying the Safety of NOACs in the Real World

Tailoring Hemophilia Prophylaxis Therapy

What Does the Primary Care Physician Need to Know About Chronic Hepatitis C?

Expert Perspectives on HSCT: Planning for Success

A Frontline Clinician's Guide to Managing Opioid-Induced Constipation

Team-Based Perspectives on Successful Approaches in Treating Obesity

Introduction. A Reality Check on BP Goals and Optimizing Patient Adherence to Treatment.

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.

Individualizing Factor Replacement Therapy for Patients With Hemophilia.

EHL Technologies in Hemophilia Care

Issues in the Management of Hemophilia: A Best Practice Series

A Better Solution For Cancer Patients With VTE?

Exploring Personalized Prophylaxis in Hemophilia A

Real-World Evidence in VTE

Guided by Objective Measures: Challenging Case Scenarios in Rheumatoid Arthritis.

Case: A 28-Year-Old Man. When a 5-ASA Agent No Longer Maintains Remission in a Patient With Ulcerative Colitis.

Innovations in Home Care

EARLY Combination Therapy in PAH: What Every Cardiologist Needs to Know.

Tools to Address Adherence Issues in Patients With SIHD

I PRO' -.._ r.. f FOLLOW I 0.

Program Goals. Technological Advances in Longer-Acting Factor Replacement Therapy for Hemophilia.

Key Questions for nAMD Treatment Success

Multidisciplinary Approaches to Managing Hemophilia

What Does It Take to Be a Long-Acting Replacement Therapy in Hemophilia A?

When Is Intrathecal Drug Delivery Appropriate?

Program. Basal Insulin in the Modern Era The CDE's Role in Improving Utilization and Outcomes.

Prolonging the Effects of Factor IX Replacement Therapy in Hemophilia B.

CAD/PAD in Primary Care

Cancer-Associated Thrombosis

Viewpoints of Practicing Rheumatologists: Case Discussions in RA

Managing Your Patient’s Maintenance Therapy for Multiple Myeloma

Managing Age-Related Clinical Issues in Hemophilia

Extended Half-life Factor Products in the Management of Hemophilia

Program Goals Disclaimers Defining Refractory Seizures.

Updates From the 2015 Meetings in Hemophilia

Optimizing Targeted Therapy for HER2-Positive Advanced Breast Cancer: Considerations for Previously Treated Disease.

The Adherence Challenge in Schizophrenia Roles of Current and Emerging Therapies.

Optimizing Joint Health in Hemophilia

A Nursing Perspective on Improving Outcomes for Patients With Hemophilia.

Etiology and Incidence Pathophysiology Hemophilia is due to a defect in thrombin generation on the platelet surface.

Clinical Challenges and Updates in Managing Seizure Clusters

THE CONTINUUM OF CARE IN mCRC: OPTIMIZING USE OF EGFR ANTIBODIES

Navigating New Treatment Landscapes in HR+ HER2-Negative Advanced Breast Cancer.

Selecting Treatment Approaches in Hemophilia

When Is Intrathecal Drug Delivery Appropriate?

So Many Guidelines, So Little Time:

Would Patients With Hemophilia B Benefit From Switching to Extended Half-Life Factor Products?

Exploring the Use of Adeno-Associated Virus for Gene Therapy

Examining the Role of Pharmacokinetics in Hemophilia

Shared Decision Making in MS

What's New in NOACs in AF?.

Presentation transcript:

Current Challenges in Managing Hemophilia

Program Goals

Introduction

Prophylaxis vs “On-Demand” Therapy

Degrees of Hemophilia

Joint Outcome Study: Results

Continuous Factor Replacement Therapy Protocols: Definitions

SPINART: Study Design

SPINART: Results

Prophylaxis Regimens: Severe Hemophilia A

Strategies for Improving Adherence

WHO Definition of Adherence

Strategies for Improving Adherence

VERITAS-Pro Tool

Longer-Acting Factor Replacement Therapy

Summary

Abbreviations

References

References (cont)

References (cont)

References (cont)